Assessment of Oxidative DNA Damages in Radiography Staff via Evaluation of Its Urinary Biomarker (8‑hydroxy2‑deoxyguanosine)

Azam Salehi, Karim Ebrahimpour, Farhad Forouharmajd, Maryam Zarean

Abstract


Background: Studies have shown that one of the most important complications of exposure to ionizing radiation is the emergence of cancer tumors, as a result of oxidative DNA. Since different radiography groups have high rate of exposure to ionizing radiation, examining the susceptibility rate of cancer in these groups is of prime importance. Therefore, the present study was conducted to measure the level of 8‑hydroxy2‑deoxyguanosine (8‑OHdG) in the radiographers’ urine as a biomarker of oxidative damage while comparing it with the nonradiography staff.

Methods: Samples of two groups were selected for this case‑control study, wherein 35 subjects were selected from different radiography groups (including nuclear medicine, radiology, radiotherapy, and CT scan) while the other 35 subjects were staffs who had no exposure to radiation. Later, urine samples were collected at the end of the working shift to determine the 8‑OHdG concentration. The samples were obtained via SPE (solid‑phase extraction) method. Subsequently, the 8‑OHdG concentration was measured by the GC‑MS analyzer.

Results: The results confirmed that, the average concentration of 8‑OHdG in the radiographers’ urine (253.4 ± 31.2 ng/mg of creatinine) had a significant difference as compared to the nonradiographers’ urine (141.1 ± 21.9 ng/mg of creatinine) (P = 0.004).

Conclusions: In conclusion, due to elimination of interfering factors, ionizing radiation affects the increase in 8‑OHdG levels and acts as a potential biomarker for the damaged oxidative DNA.


Keywords


8‑hydroxy2‑deoxyguanosine; oxidative DNA; radiography staff

Full Text:

PDF

References


Gao L. ROS‑induced DNA adducts in the rodents after exposure

to superfund hazardous chemicals. PhD thesis 2011.

Hallberg LM, Ward JB, Hernandez C, Ameredes BT,

Wickliffe JK, Committee HHR. Part assessment of genotoxicity

and oxidative damage in rats after chronic exposure to

new‑technology diesel exhaust in the ACES bioassay. Res Rep

Health Eff Inst 2015;184:87‑105.

Płachetka A, Adamek B, Strzelczyk JK, Krakowczyk Ł,

Migula P, Nowak P, et al. 8‑hydroxy‑2′‑deoxyguanosine in

colorectal adenocarcinoma–is it a result of oxidative stress? Med

Sci Monit 2013;19:690‑5.

Jacob KD, Hooten NN, Trzeciak AR, Evans MK. Markers of

oxidant stress that are clinically relevant in aging and age‑related

disease. Mech Ageing Dev 2013;134:139‑57.

Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli L,

Kruszewski M, et al. The comet assay: Topical issues.

Mutagenesis 2008;23:143‑51.

Evans MD, Olinski R, Loft S, Cooke MS. Toward consensus in

the analysis of urinary 8‑oxo‑7, 8‑dihydro‑2′‑deoxyguanosine

as a noninvasive biomarker of oxidative stress. The FASEB J

;24:1249‑60.

Betlazar C, Middleton RJ, Banati RB, Liu GJ. The impact of

high and low dose ionising radiation on the central nervous

system. Redox Biol 2016;9:144‑56.

Slot C. Plasma creatinine determination a new and specific Jaffe

reaction method. Scand J Clin Lab Invest 1965;17:381‑7.

Hai‑Shu L, Jenner AM, Ong CN, Huang SH, Whiteman M,

Halliwell B. A high‑throughput and sensitive methodology for

the quantification of urinary 8‑hydroxy‑2′‑deoxyguanosine:

Measurement with gas chromatography‑mass spectrometry after

single solid‑phase extraction. Biochem J 2004;380:541‑8.

Lim KS, Jenner A, Halliwell B. Quantitative gas chromatography

mass spectrometric analysis of 2′‑deoxyinosine in tissue DNA.

Nat Protoc 2006;1:1995.

Ren C, Fang S, Wright RO, Suh H, Schwartz J. Urinary

‑hydroxy‑2′‑deoxyguanosine as a biomarker of oxidative DNA

damage induced by ambient pollution in the normative aging

study. Occup Environ Med 2011;68:562‑9.

Commodore AA, Zhang JJ, Chang Y, Hartinger SM,

Lanata CF, Mäusezahl D, et al. Concentrations of urinary

‑hydroxy‑2′‑deoxyguanosine and 8‑isoprostane in women

exposed to woodsmoke in a cookstove intervention study in San

Marcos, Peru. Environ Int 2013;60:112‑22.

Kim JY, Mukherjee S, Ngo LC, Christiani DC. Urinary

‑hydroxy‑2′‑deoxyguanosine as a biomarker of oxidative DNA

damage in workers exposed to fine particulates. Environ Health

Perspect 2004;112:666.

Kato S, Yoshimura K, Kimata T, Mine K, Uchiyama T,

Kaneko K. Urinary 8‑hydroxy‑2′‑deoxyguanosine: A biomarker

for radiation‑induced oxidative DNA damage in pediatric cardiac

catheterization. J Pediatr 2015;167:1369‑74.e1.

Rahimipour S, Javadi I. DNA damage in radiology staff. 14th

Congress of Toxicology; 2017.

Mei S, Yao Q, Wu C, Xu G. Determination of urinary

‑hydroxy‑2′‑deoxyguanosine by two approaches—capillary

electrophoresis and GC/MS: An assay for in vivo oxidative DNA

damage in cancer patients. J Chromatogr B 2005;827:83‑7.

Radiation Protection Guidance For Hospital Staff. Prepared for

Stanford Health Care, Stanford Children’s Health and Veterans

Affairs Palo Alto Health Care System 2017.

Sackett G. Radiation Safety Issues for Radiologic Technologies.

Presentation New York: Integrated Science Support, Radiology

Safety; 2017.

Noda N, Wakasugi H. Cancer and oxidative stress. JMAJ

;44:535‑9.

Rahimi R, Sharafi H. The effect of a bout of resistance exercise

on 8‑Hydroxy‑2′‑Deoxyguanosine in athletes and non‑athletes.

Knowledge Health 2012;7:1‑7.